Related scientific articles (all)

The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO).

Authors : Popescu RA, Schäfer R, Califano R, Eckert R, Coleman R, Douillard JY, Cervantes A, Casali PG, Sessa C, van Cutsem E, De Vries E, Pavlidis N, Fumasoli K, Wörmann B, Samonigg H, Cascinu S, Cruz Hernández JJ, Howard AJ, Ciardiello F, Stahel RA, Piccart-Gebhart M
Year : 2014
Journal : Ann Oncol
Volume : 25(1)
Pages : 9-15

Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2.

Authors : Rugo HS, Pritchard KI, Gnant M, Noguchi S, Piccart-Gebhart M, Hortobagyi G, Baselga J, Perez A, Geberth M, Csoszi T, Chouinard E, Srimuninnimit V, Puttawibul P, Eakle J, Feng W, Bauly H, El-Hashimy M, Taran T, Burris HA
Year : 2014
Journal : Ann Oncol
Volume : 25(4)
Pages : 808-15

Luminal B Breast Cancer: Molecular Characterization, Clinical Management, and Future Perspectives.

Authors : Ades F, Zardavas D, Bozovic-Spasojevic I, Pugliano L, Fumagalli D, de Azambuja E, Viale G, Sotiriou C, Piccart-Gebhart M
Year : 2014
Journal : J. Clin. Oncol.
Volume : 32(25)
Pages : 2794-803

Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial.

Authors : Bonnefoi H, Litière S, Piccart-Gebhart M, Macgrogan G, Fumoleau P, Brain E, Petit T, Rouanet P, Jassem J, Moldovan C, Bodmer A, Zaman K, Cufer T, Campone M, Luporsi E, Malmström P, Werutsky G, Bogaerts J, Bergh J, Cameron DA
Year : 2014
Journal : Ann Oncol
Volume : 25(6)
Pages : 1128-36

A phase I pharmacokinetics study of lapatinib and tamoxifen in metastatic breast cancer (EORTC 10053 Lapatam study).

Authors : Fumoleau P, Koch KM, Brain E, Lokiec F, Rezai K, Awada A, Hayward L, Werutsky G, Bogaerts J, Marréaud S, Cardoso F
Year : 2014
Journal : Breast
Volume : 23(5)
Pages : 663-9

A rare case of prostatic extra gonadal germ cell tumor in a young adult: Review of the literature

Authors : Sideris S, Aftimos P, Georgala A, Sirtaine N, Awada A, Gil T
Year : 2014
Journal : J Clin Diagn Res
Volume : 2
Pages : 2

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.

Authors : Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N, Bonnefoi H, Cameron D, Gianni L, Valagussa P, Swain SM, Prowell T, Loibl S, Wickerham DL, Bogaerts J, Baselga J, Perou C, Blumenthal G, Blohmer J, Mamounas EP, Bergh J, Semiglazov V, Justice R, Eidtmann H, Paik S, Piccart-Gebhart M, Sridhara R, Fasching PA, Slaets L, Tang S, Gerber B, Geyer CE, Pazdur R, Ditsch N, Rastogi P, Eiermann W, Von Minckwitz G
Year : 2014
Journal : Lancet
Volume : 384(9938)
Pages : 164-72

The Role of Age on Dose Limiting Toxicities (DLTs) in Phase I Dose-escalation Trials.

Authors : Schwandt A, Harris PJ, Hunsberger S, Deleporte A, Smith GL, Vulih D, Anderson BD, Ivy SP
Year : 2014
Journal : Clin Cancer Res
Volume : 20(18)
Pages : 4768-75

Prospective non-interventional multicentre observational trial of first-line anti-cancer treatment in patients with metastatic renal cell cancer in Belgium.

Authors : Cornelis N, Vermassen T, Schallier D, Machiels JP, Gil T, Debruyne PR, DHondt R, Bols A, Schrijvers D, Mebis J, Lumen N, Rottey S
Year : 2014
Journal : Acta Clin Belg
Volume : 69(5)
Pages : 335-40

Delivering precision medicine in oncology today and in future-the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO).

Authors : Ciardiello F, Arnold D, Casali PG, Cervantes A, Douillard JY, Eggermont A, Eniu A, McGregor K, Peters S, Piccart-Gebhart M, Popescu R, van Cutsem E, Zielinski C, Stahel R
Year : 2014
Journal : Ann Oncol
Volume : 25(9)
Pages : 1673-8

Treatment options for pregnant women with ovarian tumors.

Authors : Mancari R, Tomasi-Cont N, Sarno MA, Azim HA, Franchi D, Carinelli S, Biglia N, Colombo N, Peccatori FA
Year : 2014
Journal : Int J Gynecol Cancer
Volume : 24(6)
Pages : 967-72

A multicenter phase 1 study of EMD 525797 (DI17E6), a novel humanized monoclonal antibody targeting av integrins, in progressive castration-resistant prostate cancer with bone metastases after chemotherapy.

Authors : Wirth M, Heidenreich A, Gschwend JE, Gil T, Zastrow S, Laniado M, Gerloff J, Zühlsdorf M, Mordenti G, Uhl W, Lannert H
Year : 2014
Journal : Eur Urol
Volume : 65(5)
Pages : 897-904

Multicenter implementation of geriatric assessment in Belgian patients with cancer: A survey on treating physicians' general experiences and expectations.

Authors : Kenis C, Heeren P, Bron D, Decoster L, Moor R, Pepersack T, Langenaeken C, Rasschaert M, Jerusalem G, Van Rijswijk R, Lobelle JP, Flamaing J, Milisen K, Wildiers H
Year : 2014
Journal : J Geriatr Oncol
Volume : 5(4)
Pages : 431-8

Maastricht delphi consensus on event definitions for classification of recurrence in breast cancer research.

Authors : Moossdorff M, van Roozendaal LM, Strobbe LJ, Aebi S, Cameron DA, Dixon JM, Giuliano AE, Haffty BG, Hickey BE, Hudis CA, Klimberg VS, Koczwara B, Kühn T, Lippman ME, Lucci A, Piccart-Gebhart M, Smith BD, Tjan-Heijnen VC, van de Velde CJ, Van Zee KJ, Vermorken JB, Viale G, Voogd AC, Wapnir IL, White JR, Smidt ML
Year : 2014
Journal : J. Natl. Cancer Inst.
Volume : 106(12)

In times of crisis, go liquid!

Authors : Hendlisz A, Deleporte A, Vandeputte C
Year : 2014
Journal : Curr Opin Oncol
Volume : 26(4)
Pages : 440

Everolimus plus exemestane as first-line therapy in HR(+), HER2 (-) advanced breast cancer in BOLERO-2.

Authors : Beck JT, Hortobagyi GN, Campone M, Lebrun F, Deleu I, Rugo HS, Pistilli B, Masuda N, Hart L, Melichar B, Dakhil S, Geberth M, Nunzi M, Heng DY, Brechenmacher T, El-Hashimy M, Douma S, Ringeisen F, Piccart-Gebhart M
Year : 2014
Journal : Breast Cancer Res. Treat.
Volume : 143(3)
Pages : 459-67

Biology of breast cancer during pregnancy using genomic profiling.

Authors : Azim HA, Brohée S, Peccatori FA, Desmedt C, Loi S, Lambrechts D, Dell orto P, Majjaj S, Jose V, Rotmensz N, Ignatiadis M, Pruneri G, Piccart-Gebhart M, Viale G, Sotiriou C
Year : 2014
Journal : Endocr Relat Cancer
Volume : 21
Pages : 545-54

Evaluating the physiological reserves of older patients with cancer: the value of potential biomarkers of aging?

Authors : Pallis AG, Hatse S, Brouwers B, Pawelec G, Falandry C, Wedding U, Dal Lago L, Repetto L, Ring A, Wildiers H
Year : 2014
Journal : J Geriatr Oncol
Volume : 5(2)
Pages : 204-18

Present and future breast cancer management--bench to bedside and back: a positioning paper of academia, regulatory authorities and pharmaceutical industry.

Authors : Bartsch R, Frings S, Marty M, Awada A, Berghoff AS, Conte P, Dickin S, Enzmann H, Gnant M, Hasmann M, Hendriks HR, Llombart A, Massacesi C, Von Minckwitz G, Penault-Llorca F, Scaltriti M, Yarden Y, Zwierzina H, Zielinski CC
Year : 2014
Journal : Ann Oncol
Volume : 25(4)
Pages : 773-80

Locoregional treatment of breast cancer during pregnancy.

Authors : Toesca A, Gentilini O, Peccatori F, Azim HA, Amant F
Year : 2014
Journal : Gynecol Surg
Volume : 11(4)
Pages : 279-284